Asian Hospital and Medical Centre (AHMC) launches the Interstitial Lung Disease (ILD) Center in the newly established Asian Institute of Respirology (AIR) under a program initiative supported by Boehringer Ingelheim (Philippines) Inc.
Dr. Lenora Fernandez, Program Director of Asian Institute of Respirology (AIR), announces, “We are launching the first center of excellence under the AIR, which will be our ILD clinic. Our mission is to deliver accessible, world-class pulmonary specialized healthcare services to every individual.”

The ILD Center will serve as a specialized facility dedicated to the comprehensive management of interstitial lung disease, a rare and complex condition. It will integrate advanced diagnostics, personalized treatment options, and ongoing support services to streamline and enhance the ILD journey from pre-diagnosis to management.
Dr. Giovanni Nazario, Medical Advisor, Specialty Care, Boehringer Ingelheim (Philippines) Inc., highlighted its significance, “By working closely with our esteemed partners from Asian Hospital, we aim to ensure that those affected by this disease have access to the best possible care and support.”
The launch of ILD Center marks a significant advancement in the management of interstitial lung disease. Asian Hospital is dedicated to advancing research, providing world-class healthcare, and enhancing the quality of life for ILD patients in the Philippines.